Short Summary
Databricks petitions the PTAB to review U.S. Patent 8,275,827, asserting that key claims are obvious over prior‑art storage systems (Carter, OceanStore, Gibson) and should be invalidated.
Detailed Summary
Databricks, Inc. has filed an Inter Partes Review petition against ByteWeavr, LLC’s ’827 patent covering software‑based network‑attached storage services. The petitioner challenges claims 2, 10‑12, 14, and 22‑24 on three grounds of obviousness: (1) over the Carter system, (2) over OceanStore, and (3) over Carter in view of Gibson. The petition also invokes collateral estoppel for claims 2 and 14, citing earlier IPRs that invalidated related claims. Detailed claim constructions are provided, aligning with prior Board decisions. The petitioner argues that discretionary denial under Fintiv, General Plastics, and §325(d) is unwarranted and requests institution of the IPR.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Databricks, Inc. vs ByteWeavr, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
BOE Technology Group Co., Ltd. et al.vs138 East LCD Advancements Limited et al.
BOE Technology Group has filed a petition to invalidate all twelve claims of U.S. Patent 8,319,512, asserting that the claims are obvious over a combination of prior‑art LCD driver references. Six obviousness grounds are presented, each tying specific claim groups to the teachings of Saito, Her, Taguchi, and Kim.
Godbersen-Smith Construction Company d/b/a GOMACO CorporationvsGuntert & Zimmerman Const. Div., Inc.
Guntert & Zimmerman seeks Director Review of the PTAB’s Final Written Decision upholding the eligibility of its ’723 slipform paver patent. The owner alleges factual, legal, and evidentiary errors, including misapplied collateral estoppel and ignored claim‑construction issues.
WHOOP, Inc.vsOmni MedSci, Inc.
The PTAB held that WHOOP’s challenge succeeded, finding all of the asserted claims of Omni MedSci’s ‘533 patent unpatentable as obvious over Lisogurski, Carlson, and Mannheimer prior art.
Fresenius Kabi SwissBiosim, GmbH et al.vsRegeneron Pharmaceuticals, Inc.
The PTAB denied institution of the IPR in a dispute between Fresenius Kabi SwissBiosim and Regeneron Pharmaceuticals, finding that the petitioner failed to meet the required likelihood standard.
Samsung Electronics Co. Ltd. et al.vsMobile Data Technologies LLC
Samsung’s petition for Director review of a denied IPR against Mobile Data Technologies’ ’336 patent was rejected, leaving the patent intact.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.